Singapore, Nov. 8 -- Upjohn, a division of Pfizer, on 7 Nov 2019, signed a Memorandum of Understanding (MoU) with Duke-NUS Medical School, Singapore's only graduate-entry medical school, to establish a Real World Evidence (RWE) studies training curriculum for ASEAN policymakers and study conductors to standardize research methodologies across the region. Moreover, the partnership also signifies the establishment of Duke-NUS as the initiative's region Centre of Excellence (CoE), providing support and leadership given their expertise and knowledge to utilize the increasing amounts of real-world data actively generated during routine care.

The program was devised as part of Upjohn's commitment to reduce the burden of non-communicable diseas...